- Home
- HOWL vs ENGS Comparison
HOWL vs ENGS Comparison
Compare HOWL & ENGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOWL
- ENGS
- Stock Information
- Founded
- HOWL 2017
- ENGS 1998
- Country
- HOWL United States
- ENGS United Kingdom
- Employees
- HOWL N/A
- ENGS N/A
- Industry
- HOWL Biotechnology: Pharmaceutical Preparations
- ENGS
- Sector
- HOWL Health Care
- ENGS
- Exchange
- HOWL Nasdaq
- ENGS NYSE
- Market Cap
- HOWL 53.8M
- ENGS 45.6M
- IPO Year
- HOWL 2021
- ENGS 2025
- Fundamental
- Price
- HOWL $1.21
- ENGS $1.67
- Analyst Decision
- HOWL Strong Buy
- ENGS
- Analyst Count
- HOWL 3
- ENGS 0
- Target Price
- HOWL $8.33
- ENGS N/A
- AVG Volume (30 Days)
- HOWL 490.7K
- ENGS 620.5K
- Earning Date
- HOWL 08-07-2025
- ENGS 01-01-0001
- Dividend Yield
- HOWL N/A
- ENGS N/A
- EPS Growth
- HOWL N/A
- ENGS N/A
- EPS
- HOWL N/A
- ENGS N/A
- Revenue
- HOWL $1,143,000.00
- ENGS $12,134,254.00
- Revenue This Year
- HOWL N/A
- ENGS N/A
- Revenue Next Year
- HOWL N/A
- ENGS N/A
- P/E Ratio
- HOWL N/A
- ENGS N/A
- Revenue Growth
- HOWL N/A
- ENGS 59.88
- 52 Week Low
- HOWL $0.60
- ENGS $1.36
- 52 Week High
- HOWL $4.18
- ENGS $10.24
- Technical
- Relative Strength Index (RSI)
- HOWL 51.44
- ENGS N/A
- Support Level
- HOWL $1.19
- ENGS N/A
- Resistance Level
- HOWL $1.35
- ENGS N/A
- Average True Range (ATR)
- HOWL 0.13
- ENGS 0.00
- MACD
- HOWL -0.02
- ENGS 0.00
- Stochastic Oscillator
- HOWL 21.84
- ENGS 0.00
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.
About ENGS ENERGYS GROUP LTD
Energys Group Ltd provides end-to-end customized solutions and services involving the retrofitting of existing infrastructure to reduce their CO2 emissions. The Company's customers include large national account end-users, including universities, schools, hospitals and electrical distributors in the United Kingdom.